Bisphosphonates as a Tacrolimus-Sparing Strategy in Kidney Transplantation: Insights from a Retrospective Analysis.

Yonsei Med J · 2026 · PMC12748278 · PMID 41431409

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep =0.06so close (0.05 < p ≤ 0.1)

Although the incidence of acute rejection was lower among bisphosphonate users compared to non-users, the difference did not reach statistical significance (17.1% vs. 22.0%, p =0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.